[1]张东方,王 茜,李 娟,等.高龄妊娠期糖尿病患者血清miR-351，FGF19 和LP-PLA2 表达水平及其与产后糖代谢异常的相关性研究[J].现代检验医学杂志,2023,38(01):66-72.[doi:10.3969/j.issn.1671-7414.2023.01.013]
　ZHANG Dong-fang,WANG Qian,LI Juan,et al.Serum miR-351, FGF19 and LP-PLA2 Expression Levels in Elderly Patients with Gestational Diabetes Mellitus and Their Correlation with Abnormal Postpartum Glucose Metabolism[J].Journal of Modern Laboratory Medicine,2023,38(01):66-72.[doi:10.3969/j.issn.1671-7414.2023.01.013]
点击复制

高龄妊娠期糖尿病患者血清miR-351，FGF19 和LP-PLA2 表达水平及其与产后糖代谢异常的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年01期
页码:
66-72
栏目:
论著
出版日期:
2023-01-15

文章信息/Info

Title:
Serum miR-351, FGF19 and LP-PLA2 Expression Levels in Elderly Patients with Gestational Diabetes Mellitus and Their Correlation with Abnormal Postpartum Glucose Metabolism
文章编号:
1671-7414（2023）01-066-07
作者:
张东方;  王 茜;  李 娟;  庄敏敏
（唐山市妇幼保健院产科，河北唐山 063000）
Author(s):
ZHANG Dong-fang; WANG Qian; LI Juan; ZHUANG Min-min
（Department of Obstetrics, Tangshan Maternal and Child Health Hospital, Hebei Tangshan 063000，China）
关键词:
高龄孕妇; 妊娠期糖尿病; 微小核糖核酸-351; 纤维细胞生长因子19; 脂蛋白相关磷脂酶A2
分类号:
R714.256；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.01.013
文献标志码:
A
摘要:
目的 探讨高龄妊娠期糖尿病（gestational diabetes mellitus，GDM）患者微小核糖核酸（micro RNA，miR）-351， 纤维细胞生长因子19（fibroblast growth factor 19，FGF19）， 脂蛋白相关磷脂酶A2（lipoprotein-associatedphospholipase A2，LP-PLA2）表达及与产后糖代谢异常的相关性。方法 选取2019 年1 月～ 2022 年1 月唐山市妇幼保健院高龄GDM 患者86 例为观察组，同期选取产检的正常高龄孕妇52 例为对照组。比较两组血清miR-351，FGF19 和LP-PLA2 表达，分析高龄GDM 患者miR-351，FGF19 和LP-PLA2 与产后糖脂代谢指标相关性，Logistic 回归分析高龄GDM 患者产后糖代谢异常影响因素，受试者工作特征（ROC）分析miR-351，FGF19 和LP-PLA2 对产后糖代谢异常预测价值。结果 观察组血清空腹血糖（FPG）（5.93±0.61mmol/L），空腹胰岛素（FINS）（15.82±4.19mU/L）, 胰岛素抵抗指数（MOHA-IR）（4.31±0.64）, 三酰甘油（TG）（1.46±0.28mmol/L），低密度酯蛋白- 胆固醇（LDL-C）（2.93±0.66mmol/L），miR-351（6.42±1.76），LP-PLA2 活性（33.09±6.51nmol/min·ml）高于对照组（4.48±0.76mmol/L, 11.65±3.90m/U/L，2.45±0.57, 1.32±0.24mmol/L，2.58±0.59mmol/L，3.79±1.14，24.52±5.83nmol/min·ml），而FGF19（91.18±8.64ng/L）水平低于对照组（122.63±10.29ng/L），差异均有统计学意义（t=2.999~17.226，均P ＜ 0.05）；高龄GDM 患者血清miR-351 水平、LP-PLA2 活性与空腹血糖（fasting plasma glucose，FPG）、空腹胰岛素(fasting insulin，FINS)、胰岛素抵抗指数（insulin resistance index，HOMA-IR）、三酰甘油（triglyceride，TG）和低密度脂蛋白- 胆固醇（low densitylipoprotein，LDL-C）呈正相关（r=0.408 ～ 0.584，均P ＜ 0.05），血清FGF19 水平与FPG，FINS 和HOMA-IR 呈负相关（r=-0.614 ～ -0.386，均P ＜ 0.05）；高龄GDM 患者miR-351 与FGF19 呈负相关（r=-0.531，P ＜ 0.001），与LPPLA2呈正相关（r=0.549，P ＜ 0.001），FGF19 与LP-PLA2 呈负相关（r=-0.614，P ＜ 0.001）。Logistic 回归模型分析显示，miR-351，LP-PLA2 活性升高及FGF19 降低均为高龄GDM患者产后糖代谢异常独立危险因素（P ＜ 0.05）；ROC曲线显示，miR-351，LP-PLA2 和FGF19 对GDM 患者产后糖代谢异常均有一定预测价值，且联合预测的AUC 达0.854，对应的敏感度和特异度分别为90.16% 和68.35%。结论 血清miR-351，FGF19 和LP-PLA2 参与GDM 发生发展，可对患者体内糖脂代谢产生影响，且可有效预测产后糖代谢异常发生风险，为临床干预提供依据。
Abstract:
Objective To investigate the microRNA (miR) -351, fibroblast growth factor 19 (FGF19) and lipoprotein-associated phospholipase A2 (LP-PLA2) in elderly patients with gestational diabetes mellitus (GDM) expression and its correlation with abnormal postpartum glucose metabolism. Methods From January 2019 to January 2022, 86 elderly patients with GDM in Tangshan Maternal and Child Health Hospital were selected as the observation group, and 52 normal elderly pregnant women who underwent obstetric examination in the hospital during the same period were selected as the control group. The clinical characteristics and serum miR-351, FGF19 and LP-PLA2 expressions were compared between the two groups. The correlation between miR-351, FGF19, LP-PLA2 and postpartum glucose and lipid metabolism indexes in elderly GDM patients was analyzed. Logistic regression was used to analyze postpartum glucose metabolism abnormalities in elderly GDM patients.Influencing factors, receiver operating characteristic (ROC) analysis of the predictive value of miR-351, FGF19 and LP-PLA2 for abnormal postpartum glucose metabolism. Results Fasting plasma glucose（FPG）of observation group(5.93±0.61mmo/L vs 4.48±0.76mmol/L), fasting insulin(FINS)(15.8±4.19mU/L vs 11.65±3.90m/U/L), insulin resistance index(HOMA-IR) (4.31±0.64 vs 2.45±0.57), triglyceride (TG)(1.46±0.28mmol/L vs 1.32±0.24mmol/L), low density lipoprotein-C(LDL-C) (2.93±0.66mmol/L vs 2.58±0.59mmol/L), serum miR-351 (6.42±1.76 vs 3.79±1.14), LP-PLA2 activity (33.09±6.51nmol / min·ml vs 24.52±5.83nmol/min·ml) was higher than the control group, FGF19 level(91.18±8.64ng/L vs 122.63±10.29ng/L) level was lower than the control group, the differences were statistically significant (t=2.999~17.226, all P ＜ 0.05). Serum miR- 351 level and LP-PLA2 activity in elderly patients with GDM were positively correlated with FPG, FINS, HOMA-IR, TG and LDL-C (r=0.408 ～ 0.584，all P ＜ 0.05). Serum FGF19 level was negatively correlated with FPG, FINS, HOMA-IR (r=- 0.614~-0.386，all P ＜ 0.05)， miR-351 was negatively correlated with FGF19 in elderly GDM patients (r=-0.531, P ＜ 0.001). It was positively correlated with LP-PLA2 (r=0.549, P＜ 0.001), and FGF19 was negatively correlated with LP-PLA2 (r=-0.614, P ＜ 0.001). Logistic regression model analysis showed that HOMA-IR, miR-351 and LP - PLA2 activity and decreased FGF19 were independent risk factors for postpartum abnormal glucose metabolism in elderly GDM patients (P<0.05). Value and the AUC of the joint prediction was 0.854, the corresponding sensitivity and the specificity was 90.16% and 68.35%, respective. Conclusion Serum miR-351, FGF19 and LP-PLA2 are involved in the occurrence and development of GDM, which can affect the glucose and lipid metabolism in patients, and can effectively predict the risk of abnormal postpartum glucose metabolism, providing a basis for clinical intervention.

参考文献/References:

[1] WANG Hui , HE Hua , YU Yangfu , et al. Maternal diabetes and the risk of feeding and eating disorders in offspring: A national population-based cohort study[J]. BMJ Open Diabetes Research & Care, 2020,8(1):e001738.
[2] MILLN J M,WALUGEMBE E,SSENTAYI S,et al. Comparison of oral glucose tolerance test and ambulatory glycaemic profiles in pregnant women in Uganda with gestational diabetes using the Free Style Libre flash glucose monitoring system[J]. BMC Pregnancy and Childbirth, 2020, 20(1):635.
[3] 潘叶静, 何秋月, 陈珏. 妊娠期糖尿病孕妇产后6 ～ 12 周糖代谢异常情况及相关因素分析[J]. 全科护理, 2021,19(16):2290-2292.
PAN Yejing, HE Qiuyue,CHEN Jue.Analysis of abnormal glucose metabolism and related factors in pregnant women with gestational diabetes mellitus 6-12 weeks postpartum[J]. Chinese General Practice Nursing,2021,19(16):2290-2292.
[4] 喻荷淋, 吴艳, 蒋莉, 等. 妊娠期糖尿病患者血清FGF19 浓度的变化及与瘦素、胰岛素抵抗的关系[J].成都医学院学报, 2020, 15(5): 571-574.
YU Helin, WU Yan, JIANG Li, et al. Changes of serum FGF19 concentration and its relationship with leptin and insulin resistance in patients with gestational diabetes mellitus [J]. Journal of Chengdu Medical College,2020,15(5):571-574.
[5] NTZOUVA N I A , G I A N N O P O U L O U E ,FRAGOPOULOU E , et al. Energy intake and plasma adiponectin as potential determinants of lipoproteinassociated phospholipase A2 activity: A cross‐sectional study[J]. Lipids, 2019, 54(10): 629-640 .
[6] 张婧怡, 冯玲, 贾静, 等. miRNA-101 通过调控胎盘滋养细胞功能参与妊娠期糖尿病的发病[J]. 现代妇产科进展,2019,28(7):518-522.
ZHANG Jingyi,FENG Ling,JIA Jing,et al. miRNA-101 participates in the pathogenesis of gestational diabetes mellitus by regulating trophoblast cell function [J]. Progress in Obstetrics and Gynecology,2019,28(7):518-522.
[7] 叶志鑫, 陈渡波, 陈培松, 等. 血浆外泌体miRNAs与妊娠期糖尿病的关系[J]. 中山大学学报（医学科学版）,2021,42(3):381-391.
YE Zhixin,CHEN Dubo,CHEN Peisong,et al.Association of plasma exosomal miRNAs with gestational diabetes mellitus [J].Journal of Sun Yat-Sen University(Medical Science),2021,42(3):381-391.
[8] 中华医学会妇产科学分会产科学组, 中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014)[J]. 中国实用乡村医生杂志,2017,24(8):45-52.
Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Committee of Pregnancy with Diabetes Mellitus, China Maternal and Child Health Association. Guidelines for Diagnosis and treatment of diabetes in pregnancy (2014)[J].Chinese Practical Journal of Rural Doctor,2017,24(8):45 -52.
[9] American Diabetes Association. Standards of medical care in diabetes-2011[J].Diabetes Care,2011,34(Suppl 1):S11-S61.
[10] YAN Jin , WANG Dezhen , MENG Zhiyuan , et al.Effects of incremental endosulfan sulfate exposure and high fat diet on lipid metabolism, glucose homeostasis and gut microbiota in mice[J]. Environmental Pollution,2020, 268(Pt A):115697.
[11] 范岩峰, 钟红秀, 张雪芹, 等. 再生育的妊娠期糖尿病孕妇产后糖代谢紊乱影响因素的队列研究[J]. 实用妇产科杂志, 2021, 37(9):678-682.
FAN Yanfeng,ZHONG Hongxiu,ZHANG Xueqin,et al.The cohort study of the risk factors for the abnormal postpartum glucose metabolism in the re-birth pregnant women with the gestational diabetes mellitus[J].Journal of Practical Obstetrics and Gynecology, 2021,37(9):678-682.
[12] ZHANG Lei, ZHANG Ting, SUN Daoxu, et al.Diagnostic value of dysregulated microribonucleic acids in the placenta and circulating exosomes in gestational diabetes mellitus[J]. J Diabetes Investing,2021,12(8):1490-1500.
[13] 黄好, 贾虹, 王晓霜, 等. 妊娠期糖尿病患者胎盘组织中miRNA-508-3p 和HGF 表达水平及其对滋养细胞胰岛素抵抗的影响[J]. 吉林大学学报(医学版),2021, 47(1):187-195.
HUANG Hao,JIA Hong,WANG Xiaoshuang,et al.Expressions of miRNA-508-3p and HGF in placenta tissue of patients with gestational diabetes mellitus and their effects on trophoblast insulin resistance [J].Journal of Jilin University(Medicine Edition), 2021,47(1):187-195.
[14] JUCHNICKA I , KUZMICKI M . Influence of miRNAs in gestational diabetes mellitus development[J].Ginekologia Polska, 2021,92(8):579-582.
[15] 张晓萌.MiR-351-5p 对前体脂肪细胞3T3-L1 成脂分化的影响及作用机制[D]. 呼和浩特: 内蒙古大学,2019.
ZHANG Xiaomeng. The molecular mechanism of the miR-351-5P effects 3T3-L1 preadipocytes adipogenic differention[D]. Hohhot: Inner Mongolia University,2019.
[16] 熊雯, 周新娥, 李南. 妊娠糖尿病患者血清miR-137,miR-351 表达对妊娠结局的影响[J]. 河北医药,2021, 43(7): 1022-1025.
XIONG Wen,ZHOU Xine,LI Nan. Effects of the expressions of miR-137 and miR-351 on the pregnancy outcome of of patients with gestational diabetes mellitus[J]. Hebei Medical Journal,2021,43(7):1022-1025.
[17] 肖艳平, 付久园, 梁红艳, 等. 妊娠期糖尿病血清chemerin,CTRP9,PAPP-A 与糖脂代谢水平的相关性分析[J]. 中国妇产科临床杂志, 2020, 21(3), 285-286.
XIAO Yanping, FU Jiuyuan, LIANG Hongyan, et al.Correlation analysis of serum chemerin, CTRP9,PAPP-A and glucose and lipid metabolism levels in gestational diabetes mellitus[J]. Chinese Journal of Clinical Obstetrics and Gynecology,2020,21(3):285-286.
[18] 吴红花. 重视妊娠期高血糖分类及妊娠期糖尿病诊断标准 [J] . 中华医学杂志, 2022, 102(6) : 389-392.
WU Honghua. Focus on the importance of classification of hyperglycemia in pregnancy and diagnostic criteria for gestational diabetes mellitus [J]. National Medical Journal of China,2022,102(6):389-392.
[19] 张星星, 李杨, 周见至, 等. 3T3-L1 前脂肪细胞分化过程miRNAs 基因的表达变化[J]. 中国药房, 2013,24 (5): 401-404.
ZHANG Xingxing,LI Yang,ZHOU Jianzhi,et al.Expression changes of miRNAs in the differentiation of 3T3-L1 pre-adipocytes[J]. China Pharmacy,2013,24(5):401-404.
[20] WANG Dongyu, XU Shuqia, DING Wenjing, et al.Decreased placental and muscular expression of the fibroblast growth factor 19 in gestational diabetes mellitus[J]. Journal of Diabetes Investigation, 2019，10(1):171-181.
[21] 张艳, 刘翔, 李鸿钏, 等. 血清脂蛋白磷脂酶A2 和血浆抗凝血酶Ⅲ对2 型糖尿病患者发生缺血性脑卒中风险的评估价值[J]. 现代检验医学杂志, 2020,35(4): 71-74.
ZHANG Yan, LIU Xiang, LI Hongchuan,et al.Evaluation value of serum lipoprotein-associated phospholipase A2 and plasma antithrombin Ⅲ on the risk of ischemic stroke in patients with type 2 diabetes mellitus [J]. Journal of Modern Laboratory Medicine,2020,35(4):71-74.
[22] 陈媛, 张家佳, 肖雄, 等. 妊娠期糖尿病患者胎盘组织和血清Gal-13,TBX5,FGF19 表达水平与妊娠结局的关系[J]. 实用妇产科杂志, 2021,37(8):624-630.
CHEN Yuan, ZHANG Jiajia,XIAO Xiong,et al.Relationship between the expression of Gal-13, TBX5,FGF19 in placenta tissue and pregnancy outcome in gestational diabetes mellitus [J]. Journal of Practical Obstetrics and Gynecology,2021,37(8): 624-630.
[23] 焦延延, 姜崴. FGF19 与糖尿病炎症反应和氧化应激的相关研究[J]. 临床与病理杂志, 2018, 38(3):623-627.
JIAO Yanyan, JIANG Wei. Research on the association of fibroblast growth factor 19 with oxidative stress and inflammation of diabetes mellitus[J]. Journal of Clinical and Pathological Research, 2018, 38(3):623-627.
[24] DEPAOLI A M , ZHOU Mei , KAPLAN D D , et al. FGF19 analogue as a surgical factor mimetic that contributes to metabolic effects beyond glucose homeostasis[J]. Diabetes, 2019,68(6):1315-1328.
[25] SIDDIQUI M K, SMITH G , JEAN P S, et al. Diabetes status modifies the long-term effect of lipoproteinassociated phospholipase A2 on major coronary events[J]. Diabetologia, 2021, 65(1):101-112.
[26] 李爱玲, 韩晓华, 杨艺君, 等. 妊娠期糖尿病孕妇产后糖代谢异常相关因素分析[J]. 中国妇幼保健,2018, 33(21):4860-4863.
LI Ailing, HAN Xiaohua, YANG Yijun, et al. Analysis of factors related to abnormal postpartum glucose metabolism in pregnant women with gestational diabetes mellitus [J]. Maternal and Child Health Care of China, 2018,33(21): 4860-4863.

相似文献/References:

[1]高 飞,杨红玲,王洁琳,等.妊娠期糖尿病患者红细胞分布宽度与胰岛素抵抗的相关性研究[J].现代检验医学杂志,2017,32(01):66.[doi:10.3969/j.issn.1671-7414.2017.01.018]
　GAO Fei,YANG Hong-ling,WANG Jie-lin,et al.Relationship between the Red Cell Volume Distribution Width in Patients with Gestational Diabetes and Insulin Resistance[J].Journal of Modern Laboratory Medicine,2017,32(01):66.[doi:10.3969/j.issn.1671-7414.2017.01.018]
[2]乔国昱,何亚萍,周 洁.妊娠期糖尿病并发甲状腺功能减退孕妇凝血功能指标的变化研究[J].现代检验医学杂志,2017,32(03):109.[doi:10.3969/j.issn.1671-7414.2017.03.029]
　QIAO Guo-yu,HE Ya-ping,ZHOU Jie.Study on the Alteration of Blood Coagulation Function of PregnantWomen with Pothyroidism Companied with Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(01):109.[doi:10.3969/j.issn.1671-7414.2017.03.029]
[3]肖鸽飞,李 桦,孟小军,等.孕妇FTO基因的表达与胰岛素水平相关性的研究[J].现代检验医学杂志,2017,32(05):44.[doi:10.3969/j.issn.1671-7414.2017.05.012]
　XIAO Ge-fei,LI Hua,MENG Xiao-jun,et al.Correlation Study on FTO Expression and Insulin Secretion Level in Pregnant Women[J].Journal of Modern Laboratory Medicine,2017,32(01):44.[doi:10.3969/j.issn.1671-7414.2017.05.012]
[4]刘 然.体质指数与血清C反应蛋白和糖化血红蛋白在妊娠期糖尿病诊断中的意义[J].现代检验医学杂志,2018,33(05):49.[doi:10.3969/j.issn.1671-7414.2018.05.014]
　LIU Ran.Diagnostic Significance of BMI,Serum CRP and HbA1c in Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2018,33(01):49.[doi:10.3969/j.issn.1671-7414.2018.05.014]
[5]孙　红,付翠芳,高佳丽,等.妊娠期糖尿病患者血清miR-21，PPARγ和IGF-1R表达水平与凝血功能和妊娠结局的相关性研究[J].现代检验医学杂志,2021,36(05):143.[doi:10.3969/j.issn.1671-7414.2021.05.032]
　SUN Hong,FU Cui-fang,GAO Jia-li,et al.Study on the Correlation between Serum miR-21, PPAR γ and IGF-1R Expression Levels in Patients with Gestational Diabetes and BloodCoagulation Function and Pregnancy Outcome[J].Journal of Modern Laboratory Medicine,2021,36(01):143.[doi:10.3969/j.issn.1671-7414.2021.05.032]
[6]许　航,贺　丹,罗　晴.育龄妇女年龄、孕前BMI和孕早期空腹血糖水平分布在妊娠期糖尿病预测中的价值[J].现代检验医学杂志,2021,36(05):169.[doi:10.3969/j.issn.1671-7414.2021.05.037]
　XU Hang,HE Dan,LUO Qing.Value of Age, Pre-Pregnancy Body Mass Index and Fasting Blood Glucose inEarly Pregnancy in Predicting Gestational Diabetes Mellitusamong Fertile Women[J].Journal of Modern Laboratory Medicine,2021,36(01):169.[doi:10.3969/j.issn.1671-7414.2021.05.037]
[7]徐　燕,李　晶.孕早期妇女血清人吻素、网膜素-1和Lipasin水平检测对早期预测妊娠期糖尿病发生风险的价值[J].现代检验医学杂志,2022,37(03):119.[doi:10.3969/j.issn.1671-7414.2022.03.025]
　XU Yan,LI Jing.Value of Serum Human Kisspeptin, Omentin-1 and Lipasin Levels in Early Pregnant Women for Early Prediction of the Risk of Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2022,37(01):119.[doi:10.3969/j.issn.1671-7414.2022.03.025]
[8]周 青,秦智娟,马宗丽.妊娠期糖尿病患者血清miR-450a-5p 和CREB 表达水平及临床意义[J].现代检验医学杂志,2022,37(04):102.[doi:10.3969/j.issn.1671-7414.2022.04.020]
　ZHOU Qing,QIN Zhi-juan,MA Zong-li.Expression Levels and Clinical Significance of Serum miR-450a-5p and CREB in Patients with Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2022,37(01):102.[doi:10.3969/j.issn.1671-7414.2022.04.020]
[9]钟新丽,朱红霞,刘星娅,等.妊娠期糖尿病患者肝脏激酶B1 内含子380C ＞ T 基因多态性与糖脂代谢的关系及评估疾病易感性的价值[J].现代检验医学杂志,2022,37(05):55.[doi:10.3969/j.issn.1671-7414.2022.05.012]
　ZHONG Xin-li,ZHU Hong-xia,LIU Xing-ya,et al.Relationship between Liver Kinase B1 (LKB1) Intron 380C>T Gene Polymorphism and Glucose and Lipid Metabolism in Patients with Gestational Diabetes Mellitus (GDM) and Evaluate Value in Assessing Disease Susceptibility[J].Journal of Modern Laboratory Medicine,2022,37(01):55.[doi:10.3969/j.issn.1671-7414.2022.05.012]
[10]樊娜娜,韩 清,鲁 静,等.血清1- 硬脂酰-sn- 甘油-3- 磷酰胆碱水平检测对妊娠期糖尿病的诊断价值[J].现代检验医学杂志,2022,37(06):114.[doi:10.3969/j.issn.1671-7414.2022.06.021]
　FAN Na-na,HAN Qing,LU Jing,et al.Diagnostic Value of Serum 1-Stearoyl-sn-Glycero-3-Phosphorylcholine Level in Gestational Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2022,37(01):114.[doi:10.3969/j.issn.1671-7414.2022.06.021]

备注/Memo

备注/Memo:
基金项目：河北省医学科学研究课题计划项目（20221770）。
作者简介：张东方（1975-），女，硕士，主治医师，研究方向：妊娠期糖尿病，E-mail：dongdang7506@sina.com。
更新日期/Last Update: 2023-01-15